Back to the main directory
Target Price Change / Equity
- Obic Business Consultants (4733 JP)(Neutral) 20/3 Q1 results: operating profits up 52% on sustained growth in upgrade demand by Nomura Research
- TVS Motor (TVSL IN, Reduce) - 1Q better on lower input costs; weak outlook by Nomura Research
- U.S. Lodging REITs - 2Q RevPAR Weakness Is Bleeding into 2H19 by Nomura Instinet Research
- ã‚ヤノンマーケティングジャパン (8060 JP)(Buy) 決算コメント by Nomura Research
- AAC テクノãƒã‚¸ãƒ¼ã‚º(Buy → Neutral)回復ã«ã¯æ™‚é–“ãŒã‹ã‹ã‚‹è¦‹è¾¼ã¿ by Nomura Research
- 日立ãƒã‚¤ãƒ†ã‚¯ãƒŽãƒã‚¸ãƒ¼ã‚º (8036 JP)(Buy) 決算コメント by Nomura Research
- Hitachi High-Technologies (8036 JP)(Buy) 20/3 Q1 results by Nomura Research
- ã‚ヤノン (7751 JP)(Neutral) 決算コメント (ADR : CAJ US) by Nomura Research
- ãƒã‚¹ã‚³(Buy)循環的ãªå›žå¾©å±€é¢ã«å‚™ãˆã‚‹(2) by Nomura Research
- Melco Resorts & Entertainment Limited - Impressive Share Gains in 2Q by Nomura Instinet Research
- LG Chem (051910 KS, Buy) - EV battery signals further growth by Nomura Research
- Hyundai Mobis (012330 KS, Buy) - Our top pick in the sector; upgrade to Buy by Nomura Research
- ICICI Prudential Life Insurance (IPRU IN, Buy) - Maintain Buy; big surprise on protection by Nomura Research
- Facebook, Inc. - Solid 2Q; Visibility on Regulatory Oversight by Nomura Instinet Research
- レーティングä¿ç•™ã®ãŠçŸ¥ã‚‰ã› - エフテックã€å¤ªå¹³æ´‹å·¥æ¥ã€ãƒ¨ãƒã‚º by Nomura Research
- Notice of suspension of rating - F-Tech, Pacific Industrial, Yorozu by Nomura Research
- 日清製粉グループ本社 (2002 JP)(Neutral) 米国製粉事æ¥ãŒè‹¦æˆ¦ã€åŽ³ã—ã„出足 by Nomura Research
- ä¸å¤–製薬 (4519 JP)(Neutral) 4～6月期決算コメントï¼å¥½èª¿ãªQ2 by Nomura Research
- Merry (2439 TT, Neutral) - Downgrade to Neutral by Nomura Research
- 日産自動車 (7201 JP)(Neutral) 円高ã€è²©å£²ä¸æŒ¯ã§ä»ŠæœŸè¨ˆç”»é”æˆå›°é›£ã¨äºˆæƒ³ by Nomura Research
- ペイパル・ホールディングス(Buy)第2å››åŠæœŸæ±ºç®—ï¼šãƒ•ã‚¡ãƒ³ãƒ€ãƒ¡ãƒ³ã‚¿ãƒ«ã‚ºå …èª¿ by Nomura Instinet Research
- Disco (6146 JP)(Buy) 20/3 Q1 results by Nomura Research
- Great Wall Motor (2333 HK, Reduce) - Maintain Reduce with lower HKD3.40 TP by Nomura Research
- Bank of Baroda (BOB IN, Buy) - Risks remain but valuations undemanding by Nomura Research
- ViTrox Corp Bhd (VITRO MK, Buy) - 2Q19 results missed expectations by Nomura Research